Role of long non-coding RNAs in sarcoma pathogenesis
Role of long non-coding RNAs in sarcoma pathogenesis
批准号:
9883636
负责人:
Eric Alejandro Sweet-Cordero
金额:
$37.6万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-03-13 至 2022-02-28
关键词:
Adolescent and Young AdultAgarAutomobile DrivingBindingBiochemicalBiologicalBiological ModelsCancer BiologyCell LineCellsChIP-seqChildChromatinColon CarcinomaDNADNA BindingDataDiseaseEnhancersEventEwings sarcomaExclusionFLI1 Transcription FactorFamilyGene ExpressionGene Expression RegulationGenesGeneticGenomicsGoalsGrowthHistonesIn VitroLeadMaintenanceMalignant NeoplasmsMalignant neoplasm of prostateMediatingMesenchymal DifferentiationModelingMolecularMorbidity - disease rateOncogenicPathogenesisPatientsPatternProteinsProteomicsRNARNA-Binding Protein EWSRNA-Binding ProteinsRoleSiteTestingTranscriptTumor SuppressionUntranslated RNAWorkXenograft procedurebonechildhood sarcomachromatin isolation by RNA purification sequencingchromatin remodelingexperimental studygene repressiongenetic signaturegenome-widein vivoknock-downmembermortalitynoveloverexpressionprotein functionprotein protein interactionrare cancersarcomatranscription factortranscriptometranscriptome sequencingtumortumor growthtumor progressiontumorigenesisyoung adult
中文摘要
项目摘要
尤文肉瘤是一种罕见的肿瘤,发生在儿童和年轻人。在这一过程中,
疾病最常见的是易位EWS/FLI。涉及ETS转录的类似易位
因素发生在其他恶性肿瘤,包括前列腺癌,扩大了我们的潜在相关性,
问题研究先前的工作已经确定,EWS/FLI可以通过抑制一些染色质重编程来导致染色质重编程。
增强子,同时通过直接结合激活其他增强子。我们自己的数据表明,EWS/FLI还
上调lncRNA的表达。该提案的主要目标是阐明
尤文肉瘤中的lncRNAs我们的初步数据表明,两个lncRNA,EWSAT 1和EWSAT 2,可能是
参与尤文肉瘤的致癌作用。这些RNA中的任何一种的敲低都会强烈降低
体外和体内尤文瘤的增殖。此外,RNAseq分析表明,这两个
lncRNA抑制大量基因,也已知被EWS/FLI抑制。我们的主要目标是
该建议旨在阐明这些lncRNA通过何种分子功能来促进Ewing
肉瘤。我们将集中研究这些lncRNA如何导致转录抑制。
在目标1中,我们将阐明EWSAT 1和2的表达如何改变细胞中关键的蛋白质-蛋白质相互作用。
尤因细胞。具体来说,我们将检验EWSAT 1或2表达改变EWS/FLI的PPI的假设,
EWS或hnRNPK。在目标2中,我们将检验EWSAT 1或2通过调节以下能力发挥作用的假设:
EWS/FLI与特异性增强子结合。ChIPseq和ChIRPseq将被用于确定这些lncRNA如何在细胞内表达。
与染色质相互作用以及它们如何改变组蛋白和其他染色质调节剂的结合。在目标3中,我们
使用Ewing患者来源的EWSAT 1/2基因,阐明EWSAT 1/2缺失或过表达的功能后果。
异种移植物和细胞系。
英文摘要
PROJECT SUMMARY
Ewing sarcoma is a rare tumor that occurs in children and young adults. The driving oncogenic event in this
disease is most commonly the translocation EWS/FLI. Similar translocations involving ETS transcription
factors occur in other malignancies, including prostate cancer, broadening the potential relevance of our
studies. Prior work has determined that EWS/FLI can lead to chromatin reprogramming by repressing some
enhancers while activating others through direct binding. Our own data indicates that EWS/FLI also
upregulates expression of lncRNAs. The primary goal of this proposal is to elucidate the molecular function of
lncRNAs in Ewing sarcoma. Our preliminary data indicates that two lncRNAs, EWSAT1 and EWSAT2, may be
involved in the oncogenic effects of Ewing sarcoma. Knock-down of either of these RNAs strongly decreases
proliferation of Ewing tumors in vitro and in vivo. Furthermore, RNAseq analysis indicates that both of these
lncRNAs repress a significant number of genes also known to be repressed by EWS/FLI. Our primary goal in
this proposal is to elucidate the molecular function through which these lncRNAs act to promote Ewing
sarcoma. We will focus our studies on determining how these lncRNAs lead to transcriptional repression.
In Aim 1, we will elucidate define how expression of EWSAT1 and 2 alters key protein-protein interactions in
Ewing cells. Specifically, we will test the hypothesis that EWSAT1 or 2 expression alters PPIs for EWS/FLI,
EWS or hnRNPK. In Aim 2, we will test the hypothesis that EWSAT1 or 2 function by modulating the ability of
EWS/FLI to bind to specific enhancers. ChIPseq and ChIRPseq will be used to determine how these lncRNAs
interact with chromatin and how they alter binding of histones and other chromatin regulators. In Aim 3, we will
elucidate the functional consequences of EWSAT1/2 loss or overexpression using Ewing patient derived
xenografts and cell lines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Engineering 3D Osteosarcoma Models to Elucidate Biology and Inform Drug Discovery
-
批准号:10564801
-
项目类别:
-
资助金额:$66.62万
-
财政年份:2023
-
负责人:Eric Alejandro Sweet-Cordero
-
依托单位:
Mechanisms of chemotherapy response and tumor re-initiation in lung cancer
-
批准号:8843190
-
项目类别:
-
资助金额:$3.48万
-
财政年份:2014
-
负责人:Eric Alejandro Sweet-Cordero
-
依托单位:
Mechanisms of chemotherapy response and tumor re-initiation in lung cancer
-
批准号:8445299
-
项目类别:
-
资助金额:$31.89万
-
财政年份:2011
-
负责人:Eric Alejandro Sweet-Cordero
-
依托单位:
Mechanisms of chemotherapy response and tumor re-initiation in lung cancer
-
批准号:8082513
-
项目类别:
-
资助金额:$33.8万
-
财政年份:2011
-
负责人:Eric Alejandro Sweet-Cordero
-
依托单位:
Mechanisms of chemotherapy response and tumor re-initiation in lung cancer
-
批准号:8838054
-
项目类别:
-
资助金额:$34.06万
-
财政年份:2011
-
负责人:Eric Alejandro Sweet-Cordero
-
依托单位:
Mechanisms of chemotherapy response and tumor re-initiation in lung cancer
-
批准号:9032663
-
项目类别:
-
资助金额:$2.14万
-
财政年份:2011
-
负责人:Eric Alejandro Sweet-Cordero
-
依托单位:
Mechanisms of chemotherapy response and tumor re-initiation in lung cancer
-
批准号:8266328
-
项目类别:
-
资助金额:$33.86万
-
财政年份:2011
-
负责人:Eric Alejandro Sweet-Cordero
-
依托单位:
Identification of Novel Kras Effector Pathways in Lung Cancer
-
批准号:7653356
-
项目类别:
-
资助金额:$27.16万
-
财政年份:2009
-
负责人:Eric Alejandro Sweet-Cordero
-
依托单位:
Novel effectors of Kras in oncogenesis, senescence and tumor progression
-
批准号:8512665
-
项目类别:
-
资助金额:$25.41万
-
财政年份:2009
-
负责人:Eric Alejandro Sweet-Cordero
-
依托单位:
Novel effectors of Kras in oncogenesis, senescence and tumor progression
-
批准号:8840544
-
项目类别:
-
资助金额:$27.12万
-
财政年份:2009
-
负责人:Eric Alejandro Sweet-Cordero
-
依托单位:
Identification of Novel Kras Effector Pathways in Lung Cancer
-
批准号:7860576
-
项目类别:
-
资助金额:$27.22万
-
财政年份:2009
-
负责人:Eric Alejandro Sweet-Cordero
-
依托单位:
Novel effectors of Kras in oncogenesis, senescence and tumor progression
-
批准号:9050640
-
项目类别:
-
资助金额:$9.81万
-
财政年份:2009
-
负责人:Eric Alejandro Sweet-Cordero
-
依托单位:
Novel effectors of Kras in oncogenesis, senescence and tumor progression
-
批准号:8373354
-
项目类别:
-
资助金额:$27.0万
-
财政年份:2009
-
负责人:Eric Alejandro Sweet-Cordero
-
依托单位:
Research Training in Childhood Cancer
-
批准号:10495095
-
项目类别:
-
资助金额:$35.97万
-
财政年份:2007
-
负责人:Eric Alejandro Sweet-Cordero
-
依托单位:
Research Training in Childhood Cancer
-
批准号:10669238
-
项目类别:
-
资助金额:$37.94万
-
财政年份:2007
-
负责人:Eric Alejandro Sweet-Cordero
-
依托单位:
Research Training in Childhood Cancer
-
批准号:10246464
-
项目类别:
-
资助金额:$32.26万
-
财政年份:2007
-
负责人:Eric Alejandro Sweet-Cordero
-
依托单位:
Research Training in Childhood Cancer
-
批准号:9770774
-
项目类别:
-
资助金额:$31.29万
-
财政年份:2007
-
负责人:Eric Alejandro Sweet-Cordero
-
依托单位:
Tumor progression in a mouse model of lung cancer
-
批准号:7281698
-
项目类别:
-
资助金额:$13.58万
-
财政年份:2003
-
负责人:Eric Alejandro Sweet-Cordero
-
依托单位:
Tumor progression in a mouse model of lung cancer
-
批准号:6786720
-
项目类别:
-
资助金额:$13.58万
-
财政年份:2003
-
负责人:Eric Alejandro Sweet-Cordero
-
依托单位:
Tumor progression in a mouse model of lung cancer
-
批准号:7108440
-
项目类别:
-
资助金额:$13.58万
-
财政年份:2003
-
负责人:Eric Alejandro Sweet-Cordero
-
依托单位:
国内基金
海外基金
Cd(II)在NH2-Agar/PSS双网络水凝胶上的吸附行为及资源化工艺研究
-
批准号:51708204
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2017
-
负责人:周贵寅
-
依托单位: